单位：[1]Peking China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China[2]Shanghai 6 People Hosp, Dept Endocrinol, Shanghai, Peoples R China[3]Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China[4]Peking Univ, Hosp 1, Dept Endocrinol, Beijing, Peoples R China[5]Shanghai Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China
第一作者单位：[1]Peking China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Li Guang-wei,Jia Wei-ping,Pan Chang-yu,et al.Efficacy and safety of repaglinide in combination with metformin in Type 2 diabetes inadequately controlled with oral anti-diabetic drugs[J].DIABETES RESEARCH and CLINICAL PRACTICE.2008,79:S32-S33.doi:10.1016/S0168-8227(08)70727-7.
APA：
Li, Guang-wei,Jia, Wei-ping,Pan, Chang-yu,Guo, Xiao-hui&Zou, Da-jin.(2008).Efficacy and safety of repaglinide in combination with metformin in Type 2 diabetes inadequately controlled with oral anti-diabetic drugs.DIABETES RESEARCH and CLINICAL PRACTICE,79,
MLA：
Li, Guang-wei,et al."Efficacy and safety of repaglinide in combination with metformin in Type 2 diabetes inadequately controlled with oral anti-diabetic drugs".DIABETES RESEARCH and CLINICAL PRACTICE 79.(2008):S32-S33
